BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10624486)

  • 1. Diagnostic controversies: is CBD part of the "pick complex"?
    Kertesz A; Munoz DG
    Adv Neurol; 2000; 82():223-31. PubMed ID: 10624486
    [No Abstract]   [Full Text] [Related]  

  • 2. Corticobasal degeneration look-alikes.
    Bhatia KP; Lee MS; Rinne JO; Revesz T; Scaravilli F; Davies L; Marsden CD
    Adv Neurol; 2000; 82():169-82. PubMed ID: 10624481
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary progressive aphasia as the initial manifestation of corticobasal degeneration. A "three in one " syndrome?
    Ioannides P; Karacostas D; Hatzipantazi M; Ioannis M
    Funct Neurol; 2005; 20(3):135-7. PubMed ID: 16324238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Speech disturbances and dyskinesias as initial symptoms of cortico- basal degeneration].
    Anhaus S; Niederwieser G; Bonelli RM; Lind P; Reisecker F; Költringer P
    Nervenarzt; 2000 Apr; 71(4):311-5. PubMed ID: 10795100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verbal mediation of number knowledge: evidence from semantic dementia and corticobasal degeneration.
    Halpern C; Clark R; Moore P; Antani S; Colcher A; Grossman M
    Brain Cogn; 2004 Oct; 56(1):107-15. PubMed ID: 15380881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pick-body-like inclusions in corticobasal degeneration differ from Pick bodies in Pick's disease.
    Ikeda K; Akiyama H; Arai T; Tsuchiya K
    Acta Neuropathol; 2002 Feb; 103(2):115-8. PubMed ID: 11810176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging in CBD, related atypical parkinsonian disorders, and dementias.
    Savoiardo M; Grisoli M; Girotti F
    Adv Neurol; 2000; 82():197-208. PubMed ID: 10624483
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical diagnostic criteria.
    Riley DE; Lang AE
    Adv Neurol; 2000; 82():29-34. PubMed ID: 10624468
    [No Abstract]   [Full Text] [Related]  

  • 9. The current model of basal ganglia organization under scrutiny.
    Parent A; Cicchetti F
    Mov Disord; 1998 Mar; 13(2):199-202. PubMed ID: 9539330
    [No Abstract]   [Full Text] [Related]  

  • 10. Functional imaging studies in corticobasal degeneration.
    Brooks DJ
    Adv Neurol; 2000; 82():209-15. PubMed ID: 10624484
    [No Abstract]   [Full Text] [Related]  

  • 11. [A 65-year-old man with rigid-bradykinetic parkinsonism, vertical gaze palsy, difficulty of eye-lid opening, and marked pseudo-bulbar palsy].
    Noda K; Kobayashi T; Matsuoka S; Takanashi M; Kanazawa A; Mizuno Y
    No To Shinkei; 2005 Jan; 57(1):73-86. PubMed ID: 15782604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Corticobasal degeneration: clinical and neuropsychological profile].
    Felician O; Koric L; Rochefort N
    Psychol Neuropsychiatr Vieil; 2009 Jun; 7(2):91-100. PubMed ID: 19473952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticobasal syndrome: overcoming the artificial divide between disorders of cognition and movement.
    Rabinovici GD; Miller BL
    J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):404. PubMed ID: 22171068
    [No Abstract]   [Full Text] [Related]  

  • 14. Aphasia in corticobasal degeneration.
    Black SE
    Adv Neurol; 2000; 82():123-33. PubMed ID: 10624476
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuropathologic and molecular considerations.
    Dickson DW; Liu WK; Ksiezak-Reding H; Yen SH
    Adv Neurol; 2000; 82():9-27. PubMed ID: 10624467
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnostic controversies: another view.
    Duyckaerts C; Hauw JJ
    Adv Neurol; 2000; 82():233-40. PubMed ID: 10624487
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemiologic aspects.
    Togasaki DM; Tanner CM
    Adv Neurol; 2000; 82():53-9. PubMed ID: 10624470
    [No Abstract]   [Full Text] [Related]  

  • 18. Preferred terminology.
    Kertesz A; Munoz DG; Hillis A
    Ann Neurol; 2003; 54 Suppl 5():S3-6. PubMed ID: 12833360
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):658-64. PubMed ID: 12410387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical application of magnetoencephalography in a patient with corticobasal degeneration.
    Mizuno T; Takanashi Y; Nakase T; Makino M; Iwamoto K; Nakajima K; Furuya S; Naruse S; Imahori Y; Yoshida Y
    J Neuroimaging; 1999 Jan; 9(1):45-7. PubMed ID: 9922724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.